Moreover, lncRNA ACTA2-AS recruits EZH2 to the TSC2 gene promoter, suppressing TSC2 expression, inhibiting autophagy, promoting apoptosis in cisplatin-resistant NSCLC cells, and limiting tumor progression. This evidence concerns the gene TSC2 and neoplasm.